Have we made any progress in improving racial health inequities since the early 2000s? Researchers at Harvard Medical School, who published their findings in the Journal of the American College of Cardiology, wanted to find out.

If you are wondering what health care disparities might look like in medication use for chronic diseases, a new study published in JAMA Network Open can serve as just one example. Among patients with diabetes in the United States, researchers found that lower rates of SGLT2 inhibitor use, a medication with substantial cardioprotective and kidney protective benefits, is associated with Black race, Asian race, female gender, and lower household income.